Drawing for OMVAH

USPTO serial 97509038

OMVAH

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
MIZELLE HOWARD, DEZMONA JULYE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OMVAH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce W. Longbottom

LILLY CORPORATE CENTERINDIANAPOLIS, IN 46285United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 17, 2024MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jul 17, 2024ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 16, 2024EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jan 18, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 16, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 16, 2024EXT1SOU EXTENSION 1 FILED—
Jan 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 1, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 1, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2023DOCKASSIGNED TO EXAMINER—
Aug 9, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance